Blood Flow Restriction Exercise and Immune Cells in Adults With Type 2 Diabetes
Tests 6 weeks of exercise with blood flow restriction in adults with type 2 diabetes.
Plain-language title generated from the registry record
Registry title: 6-Weeks of Blood Flow Restriction Training on Immune Cell Function and Bioenergetics
Key facts
- Where
- Kelowna, CanadaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 19-64 who have type 2 diabetes and do little physical activity. It studies a 6-week blood flow restriction exercise program.
- Age
- 19 to 64 years
- Sex
- Men and women can join.
- Disease stage
- Type 2 diabetes with a current HbA1c of 5.7-9.0% (39–75 mmol/mol).
- Earlier treatment
- Diabetes medication must have been stable for the last 3 months.
- Biomarker or test result
- HbA1c between 5.7% (39 mmol/mol) and 9.0% (75 mmol/mol).
Main reasons for not taking part
- Long-lasting muscle, bone or joint condition, or a heart or blood vessel event within 2 years, that prevents exercise
- Conditions that rule out blood flow restriction training, such as peripheral vascular disease
- Low iron, anemia, or treatment for these
- Any condition that changes red blood cells, such as sickle cell anemia
- Medication that stops a heart rate monitor from tracking exercise intensity correctly
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 19 and 64 years old?
Source: NCT07676305, who can take part
Where in Canada
- University of British Columbia OkanaganKelowna, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University of British Columbia
- Trial code
- NCT07676305
- Record updated
- 2 November 2026
- Original description
To conduct a randomized control trial to determine the impact of 6-weeks of blood flow restriction training on immune cell function and bioenergetics in adults living with type 2 diabetes.Read full original descriptionShow less
Impact of 6-Weeks of Blood Flow Restriction Training on Immune Cell Function and Bioenergetics in Adults withT2D
To conduct a randomized control trial to determine the impact of 6-weeks of blood flow restriction training on immune cell function and bioenergetics in adults living with type 2 diabetes.
Inclusion: Aged 19-64 years. B. Diagnosed with type 2 diabetes with current HbA1c 5.7-9.0% C. Completing <150 minutes of moderate-vigorous physical activity per week.
Exclusion: Chronic musculoskeletal condition or recent (within 2 years) cardiovascular event preventing participation in exercise; Unstable type 2 diabetes medication of the last 3 months C. Absolute contraindications to BFR (i.e., peripheral vascular disease) D. A self-reported diagnosis of low iron concentrations, anemia, or being treated for these conditions E. A diagnosis of any red blood cell-altering condition (i.e., sickle cell anemia, poikilocytosis) F. Currently living with any cardiovascular disease, which would impact the ability to participate in exercise safely G. Currently prescribed any medication which would impact the ability to use a heart rate monitor to accurately track intensity.